P1.18-02 The AEGEAN Phase 3 Trial of Neoadjuvant/Adjuvant Durvalumab in Patients with Resectable Stage II/III NSCLCJ. Heymach,J. Taube,T. Mitsudomi, D. Harpole, M. Aperghis, L. Trani,M. Powell, P. Dennis,M. ReckJOURNAL OF THORACIC ONCOLOGY（2019）引用 29|浏览39暂无评分关键词Chemotherapy,durvalumab,NSCLCAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
